Search

Major bleeding in patients on treatment with NOACs or VKAs in real-life: clinical presentation, management and outcome

Jun 10 2016

Major bleeding in patients on treatment with NOACs or VKAs in real-life: clinical presentation, management and outcome

Limited data are available on major bleeding (MB) occurring during treatment with vitamin K (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs) outside clinical…

EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects: From Basic Science to Clinical Case Application

Dates: October 12-14, 2023
Location: Budapest, Hungary
Chairs: A Taher & A Iolascon
Collaborating SWG: EHA Specialized Working Group on Red Cells and Iron

Registration is closed

RegistrationRegistration is closed. Visit this page for more information.

EHA and Polish Society’s third tutorial together focused on myeloid and lymphoid leukemias

Oct 21 2018 Posted in Meeting reports Tagged EHA tutorial

Seventy-five participants from Europe and the Middle East learned about the advances in biology, genetic characteristics, diagnostic approaches and therapy of leukemias during the EHA-PTHiT Hematology Tutorial on Myeloid and Lymphoid Leukemias in Warsaw, Poland.

Treatment, medicine and hematology research: What patients want and doctors need (to know)

Mar 25 2014 Posted in Press releases

Jan Geissler, a Patient Advocate remarked about the Congress: “Over and above scientific updates, much can be achieved in partnership between hematologists and patients.

BENIGN HEMATOLOGY in 2023 and beyond

Jun 11 2023

The term "benign hematology" has traditionally been used to refer to non-malignant blood disorders. However, over the past few years, questions have been raised as to the appropriate nomenclature for this category of diseases.